Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
A-Z
>
ACROConnect Workshop Series >
Advancing Cell Therapy Innovation: From Early Discovery to GMP Manufacturing 
ACROBiosystems is coming to Oxford Science Park for a one-day table-top event, with a focused workshop session at the heart of it. Join us on Thursday 1st May for a full day of informal networking and expert conversations around cell and gene therapy development.
Location：Conference room 1, Sherrington Building @ Oxford Science Park
Date & Time： May 1st, 2025, 9:30AM - 3:00PM
And don’t miss the chance to win an Amazon voucher in our attendee raffle!
If you have any questions, please contact us at theo.vogiatzoglou@acrobiosystems.com or mkteu@acrobiosystems.com
This focused session explores how to select and apply reagents to support the entire cell therapy lifecycle from reproducibility in early R&D to regulatory readiness in GMP production.
Key topics include:
• Choosing the right reagents across discovery, development, and manufacturing
• Quality control and compliance considerations
• Regulatory trends and trace residue testing
• How ACRO supports developers from bench to clinic
Perfect for researchers, developers, and teams preparing to scale.
ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed to be used in discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated towards innovation to simplify and accelerate the development of new, better, and more affordable medicine.
This web search service is supported by Google Inc.
